F344/DuCrlCrlj |
serum triglyceride level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood triglyceride amount |
male |
185 days
| 9 |
203.54 |
mg/dl |
7.96 |
23.89 |
serum triglyceride analysis |
tail vein |
|
0 |
Vitros TRIG slides (Johnson & Johnson, Rochester, NY) |
11476 |
85 |
WKY/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
female |
91 days
| 5 |
40.71 |
mg/dl |
7.96 |
17.81 |
serum triglyceride analysis |
|
0 |
0 |
|
64861 |
115 |
F344/NRrrc |
serum triglyceride level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood triglyceride amount |
male |
246 days
| 21 |
131.8 |
mg/dl |
4.52 |
20.72 |
serum triglyceride analysis |
carotid artery |
|
0 |
Triglyceride E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan |
12376 |
248 |
SS.ZUC-Leprfa-/-/Slc |
serum triglyceride level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood triglyceride amount |
male |
126 days
| 7 |
1559.93 |
mg/dl |
353.89 |
936.3 |
serum triglyceride analysis |
|
0.0 |
0 |
|
101918 |
2642 |
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj |
serum triglyceride level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood triglyceride amount |
male |
218 days
| 11 |
111.7 |
mg/dl |
8.83 |
29.29 |
serum triglyceride analysis |
|
0.0 |
0 |
Wako Pure Chemicals, Tokyo, Japan |
13195 |
311 |
SHR/Izm |
serum triglyceride level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood triglyceride amount |
male |
98 days
| 10 |
10.5 |
mg/dl |
0.66 |
2.1 |
serum triglyceride analysis |
|
|
0 |
|
12448 |
263 |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
serum triglyceride level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood triglyceride amount |
male |
218 days
| 7 |
89.9 |
mg/dl |
6.73 |
17.81 |
serum triglyceride analysis |
|
0 |
0 |
Wako Pure Chemicals, Tokyo, Japan |
13193 |
311 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum triglyceride level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood triglyceride amount |
male |
218 days
| 11 |
113.5 |
mg/dl |
4.81 |
15.95 |
serum triglyceride analysis |
|
0 |
0 |
Wako Pure Chemicals, Tokyo, Japan |
13194 |
311 |
SHRSP.WKY-(Klk1-D1Rat116)/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
female |
91 days
| 5 |
77.88 |
mg/dl |
11.5 |
25.72 |
serum triglyceride analysis |
|
0 |
0 |
|
64860 |
115 |
SS.ZUC-Leprfa+/+/Slc |
serum triglyceride level |
fasting (for 16 hours) |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
blood triglyceride amount |
male |
126 days
| 6 |
102.25 |
mg/dl |
25.98 |
63.64 |
serum triglyceride analysis |
|
0.0 |
0 |
|
101917 |
2642 |
WKY/Izm |
serum triglyceride level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood triglyceride amount |
male |
113 days
| 10 |
15.0 |
mg/dl |
1.8 |
5.7 |
serum triglyceride analysis |
|
|
0 |
|
12508 |
263 |
SHRSP/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
male |
91 days
| 5 |
57.52 |
mg/dl |
10.62 |
23.75 |
serum triglyceride analysis |
|
0 |
0 |
|
64856 |
115 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum triglyceride level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood triglyceride amount |
male |
185 days
| 10 |
191.15 |
mg/dl |
12.39 |
39.18 |
serum triglyceride analysis |
tail vein |
|
0 |
Vitros TRIG slides (Johnson & Johnson, Rochester, NY) |
11474 |
85 |
F344/NSlc |
serum triglyceride level |
specific pathogen-free condition (for 210 days) then fasting (for 1 days) |
Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. |
blood triglyceride amount |
male |
218 days
| 7 |
108.4 |
mg/dl |
14.5 |
38.36 |
serum triglyceride analysis |
|
0 |
0 |
Wako Pure Chemicals, Tokyo, Japan |
13192 |
311 |
OLETF |
serum triglyceride level |
fasting (for 18 hours) |
Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44. |
blood triglyceride amount |
male |
246 days
| 23 |
218.77 |
mg/dl |
13.47 |
64.62 |
serum triglyceride analysis |
carotid artery |
|
0 |
Triglyceride E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan |
12359 |
248 |
SHR/Izm |
serum triglyceride level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood triglyceride amount |
male |
113 days
| 10 |
23.8 |
mg/dl |
3.83 |
12.1 |
serum triglyceride analysis |
|
|
0 |
|
12478 |
263 |
WKY/Izm |
serum triglyceride level |
controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then fasting (for 16 hours) |
Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87. |
blood triglyceride amount |
male |
98 days
| 10 |
11.0 |
mg/dl |
1.08 |
3.4 |
serum triglyceride analysis |
|
|
0 |
|
12499 |
263 |
SHRSP.WKY-(Klk1-D1Rat116)/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
male |
91 days
| 5 |
42.48 |
mg/dl |
7.96 |
17.81 |
serum triglyceride analysis |
|
0 |
0 |
|
64857 |
115 |
WKY/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
male |
91 days
| 5 |
24.78 |
mg/dl |
2.65 |
5.94 |
serum triglyceride analysis |
|
0 |
0 |
|
64858 |
115 |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
serum triglyceride level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood triglyceride amount |
male |
185 days
| 10 |
268.14 |
mg/dl |
14.16 |
44.78 |
serum triglyceride analysis |
tail vein |
|
0 |
Vitros TRIG slides (Johnson & Johnson, Rochester, NY) |
11478 |
85 |
SHRSP/Izm |
serum triglyceride level |
fasting (0 null) (for 16 hours) |
Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. |
blood triglyceride amount |
female |
91 days
| 5 |
50.44 |
mg/dl |
11.5 |
25.72 |
serum triglyceride analysis |
|
0 |
0 |
|
64859 |
115 |